P18146
Gene name |
EGR1 (KROX24, ZNF225) |
Protein name |
Early growth response protein 1 |
Names |
EGR-1, AT225, Nerve growth factor-induced protein A, NGFI-A, Transcription factor ETR103, Transcription factor Zif268, Zinc finger protein 225, Zinc finger protein Krox-24 |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:1958 |
EC number |
|
Protein Class |
|

Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

447 variants for P18146
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
CA361096271 rs1257729605 |
2 | A>T | No |
ClinGen gnomAD |
|
TCGA novel | 2 | A>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs768284319 CA3429954 |
6 | A>G | No |
ClinGen ExAC gnomAD |
|
CA3429956 rs202023911 |
8 | M>I | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs773869377 CA3429955 |
8 | M>T | No |
ClinGen ExAC TOPMed gnomAD |
|
CA361096414 rs1255059386 |
8 | M>V | No |
ClinGen gnomAD |
|
rs766886557 CA3429957 |
9 | Q>* | No |
ClinGen ExAC gnomAD |
|
rs199695186 CA361096460 |
9 | Q>H | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen 1000Genomes NCI-TCGA gnomAD |
rs990682316 CA128180013 |
9 | Q>L | No |
ClinGen Ensembl |
|
CA3429958 rs754190894 |
10 | L>M | No |
ClinGen ExAC gnomAD |
|
rs759886974 CA3429959 |
13 | P>L | No |
ClinGen ExAC gnomAD |
|
CA361096571 rs759886974 |
13 | P>R | No |
ClinGen ExAC gnomAD |
|
rs765498015 CA3429960 |
14 | L>V | No |
ClinGen ExAC gnomAD |
|
CA3429962 rs550077220 |
15 | Q>E | No |
ClinGen 1000Genomes ExAC TOPMed |
|
rs550077220 CA361096611 |
15 | Q>K | No |
ClinGen 1000Genomes ExAC TOPMed |
|
rs371476752 CA3429963 |
15 | Q>L | No |
ClinGen ESP ExAC |
|
rs76865845 CA128180036 |
17 | S>P | No |
ClinGen Ensembl |
|
CA3429965 rs751640347 |
19 | P>R | No |
ClinGen ExAC gnomAD |
|
CA361096712 rs1278496666 |
19 | P>S | No |
ClinGen gnomAD |
|
rs532091505 CA3429967 |
20 | F>C | No |
ClinGen 1000Genomes ExAC gnomAD |
|
CA3429966 rs532091505 |
20 | F>S | No |
ClinGen 1000Genomes ExAC gnomAD |
|
CA361096811 COSM1235205 rs1302695548 |
21 | G>E | Variant assessed as Somatic; impact. haematopoietic_and_lymphoid_tissue [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated NCI-TCGA gnomAD |
rs374447937 CA3429968 |
24 | P>A | No |
ClinGen ESP ExAC gnomAD |
|
rs547507736 CA361096906 |
24 | P>H | No |
ClinGen 1000Genomes ExAC gnomAD |
|
CA3429969 rs547507736 |
24 | P>L | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen 1000Genomes ExAC NCI-TCGA gnomAD |
TCGA novel | 25 | H>R | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs149170181 CA3429970 |
26 | S>P | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
rs547794631 CA361096998 |
28 | T>A | No |
ClinGen 1000Genomes ExAC gnomAD |
|
CA128180061 VAR_052712 rs13181973 |
28 | T>I | No |
ClinGen UniProt Ensembl dbSNP |
|
rs547794631 CA3429971 |
28 | T>P | No |
ClinGen 1000Genomes ExAC gnomAD |
|
CA128180079 rs1048942238 |
29 | M>I | No |
ClinGen TOPMed |
|
rs768374163 CA3429972 |
29 | M>L | No |
ClinGen ExAC TOPMed gnomAD |
|
CA3429974 rs142306373 |
29 | M>R | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs142306373 CA128180077 |
29 | M>T | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs768374163 CA3429973 |
29 | M>V | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
CA361097127 rs1262523327 |
31 | N>K | No |
ClinGen TOPMed |
|
rs1427288402 CA361097149 |
32 | Y>C | No |
ClinGen gnomAD |
|
rs199793033 CA3429975 |
32 | Y>D | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs1393783755 CA361097192 |
33 | P>R | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
rs1173635872 CA361097174 |
33 | P>S | No |
ClinGen gnomAD |
|
TCGA novel | 34 | K>E | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA3429978 rs368477832 |
34 | K>N | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen 1000Genomes ESP NCI-TCGA TOPMed gnomAD |
CA361097204 rs1421945241 |
34 | K>Q | No |
ClinGen gnomAD |
|
CA361097221 rs1299144028 |
34 | K>T | No |
ClinGen gnomAD |
|
rs558452520 CA3429981 |
35 | L>V | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen 1000Genomes ExAC NCI-TCGA TOPMed gnomAD |
rs764350788 CA3429985 |
36 | E>A | No |
ClinGen ExAC gnomAD |
|
COSM1317146 CA128180119 rs895031869 |
37 | E>K | haematopoietic_and_lymphoid_tissue [Cosmic] | No |
ClinGen cosmic curated TOPMed gnomAD |
TCGA novel | 39 | M>I | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA361097333 rs1561813673 |
39 | M>L | No |
ClinGen Ensembl |
|
rs577004119 CA3429986 |
39 | M>T | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA3429987 rs538748263 |
40 | L>M | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen 1000Genomes ExAC NCI-TCGA gnomAD |
rs538748263 CA128180139 |
40 | L>V | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs1283240843 CA361097348 |
41 | L>Q | No |
ClinGen gnomAD |
|
CA361097345 rs1240644594 |
41 | L>V | No |
ClinGen gnomAD |
|
TCGA novel | 41 | L>missing | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
TCGA novel | 42 | S>I | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA3429988 rs767439005 |
42 | S>N | No |
ClinGen ExAC gnomAD |
|
CA3429990 rs147932034 |
43 | N>S | No |
ClinGen ESP ExAC |
|
rs1561813700 CA361097364 |
44 | G>R | No |
ClinGen Ensembl |
|
CA361097386 rs1488875491 |
45 | A>V | No |
ClinGen TOPMed gnomAD |
|
CA128180153 rs749068859 |
47 | Q>H | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
CA3429993 rs141704626 |
48 | F>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
TCGA novel | 49 | L>F | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA3429995 rs747666166 |
50 | G>D | No |
ClinGen ExAC gnomAD |
|
rs778619028 CA3429994 |
50 | G>S | No |
ClinGen ExAC gnomAD |
|
CA128180169 rs902327219 |
52 | A>G | No |
ClinGen TOPMed |
|
rs371909472 CA3429998 |
52 | A>T | No |
ClinGen ESP ExAC gnomAD |
|
CA361097515 rs902327219 |
52 | A>V | No |
ClinGen TOPMed |
|
rs1350089260 CA361097532 |
53 | G>E | No |
ClinGen gnomAD |
|
rs202143124 CA128180173 |
54 | A>T | No |
ClinGen Ensembl |
|
CA361097550 rs1323268510 |
54 | A>V | No |
ClinGen TOPMed gnomAD |
|
CA3430001 rs763303660 |
55 | P>A | No |
ClinGen ExAC TOPMed gnomAD |
|
rs763303660 CA361097559 |
55 | P>S | No |
ClinGen ExAC TOPMed gnomAD |
|
CA3430002 rs377338719 |
56 | E>G | No |
ClinGen ESP ExAC gnomAD |
|
CA361097594 rs774647977 |
57 | G>C | No |
ClinGen ExAC |
|
CA3430003 rs774647977 |
57 | G>S | No |
ClinGen ExAC |
|
CA128180198 rs933295010 |
58 | S>T | No |
ClinGen TOPMed gnomAD |
|
rs1032087174 | 59 | G>missing | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs761876801 CA3430005 |
59 | G>S | No |
ClinGen ExAC gnomAD |
|
rs201549947 CA3430006 |
59 | G>V | No |
ClinGen 1000Genomes ExAC gnomAD |
|
TCGA novel | 60 | S>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA361097649 rs750479341 |
60 | S>N | No |
ClinGen ExAC |
|
CA3430007 rs750479341 |
60 | S>T | No |
ClinGen ExAC |
|
rs957730983 CA128180211 |
61 | N>S | No |
ClinGen TOPMed |
|
TCGA novel | 61 | N>Y | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA3430013 rs753748601 |
63 | S>N | No |
ClinGen ExAC gnomAD |
|
CA361097719 rs1232793156 |
63 | S>R | No |
ClinGen gnomAD |
|
CA3430015 rs544126669 |
64 | S>G | No |
ClinGen 1000Genomes ExAC gnomAD |
|
CA128180214 rs200514514 |
64 | S>N | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen 1000Genomes NCI-TCGA gnomAD |
TCGA novel | 64 | S>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs1401759112 CA361097764 |
65 | S>G | No |
ClinGen gnomAD |
|
rs1465687054 CA361097775 |
65 | S>N | No |
ClinGen gnomAD |
|
rs747838420 CA3430016 |
66 | S>N | No |
ClinGen ExAC gnomAD |
|
rs1449990055 CA361097799 |
66 | S>R | No |
ClinGen gnomAD |
|
rs747838420 CA361097791 |
66 | S>T | No |
ClinGen ExAC gnomAD |
|
rs541266469 CA361097811 |
67 | S>T | No |
ClinGen 1000Genomes TOPMed |
|
rs140268489 RCV000961140 |
67 | S>missing | No |
ClinVar dbSNP |
|
rs199973871 CA3430017 |
67 | S>G | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs541266469 CA128180220 |
67 | S>N | No |
ClinGen 1000Genomes TOPMed |
|
rs199973871 CA3430018 |
67 | S>R | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA128180222 CA128180224 rs200940543 |
68 | G>R | No |
ClinGen TOPMed gnomAD |
|
rs770357422 CA3430020 |
69 | G>D | No |
ClinGen ExAC gnomAD |
|
CA361097838 rs1320164238 |
69 | G>S | No |
ClinGen gnomAD |
|
CA361097854 rs1272976358 |
70 | G>D | No |
ClinGen gnomAD |
|
CA361097851 rs1580990888 |
70 | G>S | No |
ClinGen Ensembl |
|
CA3430021 rs775964046 |
71 | G>R | No |
ClinGen ExAC gnomAD |
|
CA361097870 rs1297360019 |
73 | G>D | No |
ClinGen TOPMed |
|
rs749738681 CA3430022 |
73 | G>S | No |
ClinGen ExAC gnomAD |
|
rs1017146935 CA128180230 |
74 | G>E | No |
ClinGen Ensembl |
|
rs769071689 CA3430023 |
74 | G>R | No |
ClinGen ExAC gnomAD |
|
rs774542019 CA3430024 |
75 | G>D | No |
ClinGen ExAC TOPMed gnomAD |
|
CA361097878 rs1382558474 |
75 | G>S | No |
ClinGen gnomAD |
|
CA361097885 rs1580990912 |
76 | G>D | No |
ClinGen Ensembl |
|
TCGA novel | 77 | S>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA361097894 rs1394276325 |
77 | S>R | No |
ClinGen gnomAD |
|
CA3430025 rs558985780 |
77 | S>T | No |
ClinGen 1000Genomes ExAC gnomAD |
|
CA361097899 rs1561813866 |
78 | N>S | No |
ClinGen Ensembl |
|
CA3430029 rs772158966 |
79 | S>N | No |
ClinGen ExAC TOPMed gnomAD |
|
TCGA novel | 80 | S>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA361097917 rs1374692082 |
80 | S>R | No |
ClinGen gnomAD |
|
rs773461593 CA3430030 |
82 | S>C | No |
ClinGen ExAC gnomAD |
|
rs773461593 CA361097927 |
82 | S>G | No |
ClinGen ExAC gnomAD |
|
TCGA novel | 82 | S>I | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs898320714 CA361097928 |
82 | S>N | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
CA128180254 rs898320714 |
82 | S>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
rs1342573008 CA361097937 |
83 | S>N | No |
ClinGen gnomAD |
|
TCGA novel | 84 | S>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs1580990956 CA361097943 |
84 | S>N | No |
ClinGen Ensembl |
|
CA361097953 rs1338036973 |
85 | T>I | No |
ClinGen gnomAD |
|
TCGA novel | 86 | F>A | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA361097966 rs1221374503 |
87 | N>S | No |
ClinGen gnomAD |
|
TCGA novel | 87 | N>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs1281661940 CA361097975 |
88 | P>L | No |
ClinGen TOPMed gnomAD |
|
rs760828546 CA361097993 |
90 | A>E | No |
ClinGen ExAC TOPMed gnomAD |
|
rs760828546 CA361097995 |
90 | A>G | No |
ClinGen ExAC TOPMed gnomAD |
|
CA128180260 rs1022820772 |
90 | A>T | No |
ClinGen Ensembl |
|
rs760828546 CA3430031 |
90 | A>V | No |
ClinGen ExAC TOPMed gnomAD |
|
rs766482111 CA3430032 |
91 | D>N | No |
ClinGen ExAC TOPMed gnomAD |
|
CA3430034 rs753839059 |
92 | T>A | No |
ClinGen ExAC |
|
rs200340767 CA3430037 |
94 | E>K | No |
ClinGen ExAC TOPMed gnomAD |
|
CA3430038 rs529757041 |
95 | Q>E | No |
ClinGen 1000Genomes ExAC gnomAD |
|
CA361098084 rs529757041 |
95 | Q>K | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs201259281 CA361098108 |
96 | P>A | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
TCGA novel | 96 | P>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA3430039 rs201259281 |
96 | P>S | Variant assessed as Somatic; 5.524e-05 impact. [NCI-TCGA] | No |
ClinGen 1000Genomes ExAC NCI-TCGA TOPMed gnomAD |
rs1394377857 CA361098133 |
97 | Y>C | No |
ClinGen TOPMed gnomAD |
|
CA3430040 rs777399498 |
97 | Y>N | No |
ClinGen ExAC gnomAD |
|
CA361098130 rs1394377857 |
97 | Y>S | No |
ClinGen TOPMed gnomAD |
|
rs1299769797 CA361098168 |
99 | H>D | No |
ClinGen TOPMed gnomAD |
|
rs140129794 CA3430041 |
100 | L>P | No |
ClinGen ESP ExAC |
|
CA128180274 rs879195239 |
101 | T>S | No |
ClinGen Ensembl |
|
CA361098224 rs1317735632 |
102 | A>S | No |
ClinGen TOPMed gnomAD |
|
TCGA novel | 102 | A>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA3430042 rs756776870 |
102 | A>V | No |
ClinGen ExAC gnomAD |
|
rs200402937 CA128180674 |
103 | E>G | No |
ClinGen TOPMed gnomAD |
|
rs1458032586 CA361100801 |
105 | F>L | No |
ClinGen gnomAD |
|
rs779279352 CA3430063 |
112 | N>H | No |
ClinGen ExAC gnomAD |
|
CA128180680 rs150291660 |
113 | E>K | No |
ClinGen ESP TOPMed |
|
rs772577529 CA3430065 |
121 | Y>S | No |
ClinGen ExAC gnomAD |
|
CA128180699 rs200134168 |
122 | P>S | No |
ClinGen Ensembl |
|
CA361101346 rs1341880364 |
123 | S>R | No |
ClinGen TOPMed |
|
CA361101439 rs1292289866 |
128 | L>V | No |
ClinGen gnomAD |
|
rs1332106692 CA361101456 |
129 | P>A | No |
ClinGen gnomAD |
|
CA3430068 rs199627951 |
129 | P>L | No |
ClinGen ExAC gnomAD |
|
CA361101470 rs199627951 |
129 | P>R | No |
ClinGen ExAC gnomAD |
|
rs1332106692 CA361101461 |
129 | P>S | No |
ClinGen gnomAD |
|
rs1332106692 CA361101455 |
129 | P>T | No |
ClinGen gnomAD |
|
CA3430070 rs745933125 |
131 | I>N | No |
ClinGen ExAC gnomAD |
|
CA3430071 rs769829111 |
133 | Y>C | No |
ClinGen ExAC TOPMed gnomAD |
|
CA361101630 rs1257926984 |
136 | R>C | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
rs1359191813 CA361101636 |
136 | R>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed |
rs797019589 CA128180717 |
138 | S>* | No |
ClinGen Ensembl |
|
CA361101696 rs1322007068 |
138 | S>F | No |
ClinGen TOPMed |
|
CA361101722 rs1394454708 |
140 | E>K | No |
ClinGen TOPMed |
|
CA128180725 rs28365166 VAR_029330 |
144 | N>K | No |
ClinGen UniProt TOPMed dbSNP |
|
CA361101811 rs1188987693 |
144 | N>Y | No |
ClinGen gnomAD |
|
CA128180735 rs28365164 VAR_029331 |
145 | S>R | No |
ClinGen UniProt Ensembl dbSNP |
|
rs762815487 CA3430073 |
146 | G>D | No |
ClinGen ExAC gnomAD |
|
CA361101882 rs1474289680 |
147 | N>I | No |
ClinGen gnomAD |
|
rs1580991567 CA361101890 |
148 | T>P | No |
ClinGen Ensembl |
|
CA361101934 rs1580991589 |
150 | W>C | No |
ClinGen Ensembl |
|
rs137878468 CA361101938 |
151 | P>A | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA3430075 rs137878468 |
151 | P>S | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA3430077 rs767122422 |
152 | E>K | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
rs1415768432 CA361102053 |
156 | S>T | No |
ClinGen TOPMed gnomAD |
|
CA3430080 rs765856772 |
163 | S>C | No |
ClinGen ExAC gnomAD |
|
rs767618259 CA128180748 |
163 | S>R | No |
ClinGen Ensembl |
|
rs753147814 CA3430081 |
163 | S>T | No |
ClinGen ExAC gnomAD |
|
rs758932198 CA3430082 |
164 | M>I | No |
ClinGen ExAC TOPMed gnomAD |
|
CA361102243 rs1382203641 |
164 | M>T | No |
ClinGen gnomAD |
|
rs778302593 CA3430083 |
165 | T>N | No |
ClinGen ExAC gnomAD |
|
rs1580991627 CA361102285 |
166 | N>K | No |
ClinGen Ensembl |
|
CA3430084 rs747347984 |
167 | P>S | No |
ClinGen ExAC gnomAD |
|
rs1209850719 CA361102320 |
168 | P>L | No |
ClinGen TOPMed gnomAD |
|
rs1209850719 CA361102315 |
168 | P>Q | No |
ClinGen TOPMed gnomAD |
|
CA361102318 rs1209850719 |
168 | P>R | No |
ClinGen TOPMed gnomAD |
|
rs1211585763 CA361102328 |
169 | A>P | No |
ClinGen TOPMed |
|
rs1211585763 CA361102332 |
169 | A>T | No |
ClinGen TOPMed |
|
CA128180753 rs200714449 |
169 | A>V | No |
ClinGen Ensembl |
|
rs973407190 CA128180757 |
170 | S>A | No |
ClinGen Ensembl |
|
rs149488084 CA128180760 |
170 | S>C | No |
ClinGen ESP TOPMed gnomAD |
|
rs199700793 CA361102370 |
171 | S>* | No |
ClinGen TOPMed gnomAD |
|
CA3430086 rs781257455 |
171 | S>A | No |
ClinGen ExAC gnomAD |
|
rs199700793 CA128180766 |
171 | S>L | No |
ClinGen TOPMed gnomAD |
|
CA3430090 rs201570244 |
172 | S>A | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA361102382 rs774169562 |
172 | S>C | No |
ClinGen ExAC gnomAD |
|
CA3430089 rs201570244 |
172 | S>P | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA3430091 rs201570244 |
172 | S>T | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs774169562 CA3430092 |
172 | S>Y | No |
ClinGen ExAC gnomAD |
|
CA361102402 rs1173363390 |
174 | A>T | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
TCGA novel | 175 | P>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs201215035 CA128180789 |
177 | P>S | No |
ClinGen TOPMed |
|
rs202015917 CA128180793 |
178 | A>G | No |
ClinGen TOPMed gnomAD |
|
rs202015917 CA128180796 |
178 | A>V | No |
ClinGen TOPMed gnomAD |
|
CA361102456 rs1289081010 |
179 | A>V | No |
ClinGen gnomAD |
|
CA3430095 rs767254414 |
183 | S>A | No |
ClinGen ExAC TOPMed gnomAD |
|
CA361102477 rs1305588383 |
183 | S>F | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
CA361102480 rs1389045967 COSM1567499 |
184 | A>T | large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] | No |
ClinGen cosmic curated NCI-TCGA TOPMed |
CA3430099 rs753338388 |
186 | Q>* | No |
ClinGen ExAC gnomAD |
|
TCGA novel | 186 | Q>H | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs1242903292 CA361102554 |
189 | P>L | No |
ClinGen gnomAD |
|
rs1242903292 CA361102551 |
189 | P>R | No |
ClinGen gnomAD |
|
CA128180817 rs200284757 |
191 | S>I | No |
ClinGen Ensembl |
|
rs1255480636 CA361102609 |
193 | A>E | No |
ClinGen TOPMed gnomAD |
|
rs759021865 CA3430100 |
193 | A>S | No |
ClinGen ExAC gnomAD |
|
TCGA novel | 193 | A>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs1255480636 CA361102612 |
193 | A>V | No |
ClinGen TOPMed gnomAD |
|
TCGA novel | 194 | V>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA3430101 rs764695759 |
195 | P>Q | No |
ClinGen ExAC gnomAD |
|
rs774242130 CA128180823 |
196 | S>C | No |
ClinGen TOPMed |
|
rs757711179 CA3430103 |
197 | N>K | No |
ClinGen ExAC gnomAD |
|
CA3430104 rs781553250 |
198 | D>H | No |
ClinGen ExAC gnomAD |
|
CA361102696 rs1453932337 |
199 | S>N | No |
ClinGen TOPMed |
|
TCGA novel | 205 | A>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA3430107 rs780048789 |
208 | T>P | No |
ClinGen ExAC gnomAD |
|
TCGA novel | 210 | P>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs768644189 CA3430109 |
210 | P>S | No |
ClinGen ExAC gnomAD |
|
rs201793207 CA3430110 |
211 | T>P | No |
ClinGen ExAC gnomAD |
|
CA3430111 rs748017067 |
212 | P>L | No |
ClinGen ExAC TOPMed gnomAD |
|
CA361102901 rs1224108899 |
212 | P>S | No |
ClinGen TOPMed gnomAD |
|
CA128180854 rs947294211 |
214 | T>S | No |
ClinGen TOPMed gnomAD |
|
rs201717898 CA128180858 |
215 | D>E | No |
ClinGen Ensembl |
|
rs201581445 CA3430113 |
216 | I>V | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
TCGA novel | 218 | P>A | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs1276413762 CA361103062 |
218 | P>L | No |
ClinGen TOPMed |
|
CA128180876 rs28365165 VAR_029332 |
219 | E>D | No |
ClinGen UniProt Ensembl dbSNP |
|
CA3430115 rs770593593 |
222 | S>N | No |
ClinGen ExAC gnomAD |
|
rs1210402337 CA361103201 |
223 | Q>R | No |
ClinGen gnomAD |
|
rs200345348 CA3430116 |
225 | F>L | No |
ClinGen ExAC TOPMed gnomAD |
|
CA128180890 rs995882489 |
226 | P>L | No |
ClinGen gnomAD |
|
rs1032115273 CA128180886 |
226 | P>S | No |
ClinGen TOPMed |
|
CA128180894 rs957347240 |
227 | G>A | No |
ClinGen TOPMed gnomAD |
|
rs957347240 CA361103292 |
227 | G>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed gnomAD |
CA3430119 rs201406048 |
229 | A>S | No |
ClinGen 1000Genomes ESP ExAC gnomAD |
|
CA3430118 rs201406048 |
229 | A>T | No |
ClinGen 1000Genomes ESP ExAC gnomAD |
|
rs762346051 CA3430120 |
229 | A>V | No |
ClinGen ExAC gnomAD |
|
rs1356175294 CA361103413 |
232 | A>V | No |
ClinGen gnomAD |
|
rs1580991917 CA361103450 |
235 | Y>S | No |
ClinGen Ensembl |
|
CA361103463 rs767798551 |
236 | P>L | No |
ClinGen ExAC gnomAD |
|
rs767798551 CA3430121 |
236 | P>R | No |
ClinGen ExAC gnomAD |
|
rs1372641336 CA361103480 |
237 | P>L | No |
ClinGen TOPMed |
|
CA361103501 rs1372891950 |
239 | A>T | No |
ClinGen gnomAD |
|
CA361103533 rs1226733615 |
240 | Y>S | No |
ClinGen gnomAD |
|
rs780315115 CA3430124 |
243 | A>T | No |
ClinGen ExAC gnomAD |
|
CA361103675 rs1288382551 |
245 | G>S | No |
ClinGen gnomAD |
|
rs755060107 CA3430126 |
246 | G>S | No |
ClinGen ExAC gnomAD |
|
CA361103802 rs1412243365 |
249 | V>F | No |
ClinGen gnomAD |
|
CA3430127 rs778893817 |
249 | V>G | No |
ClinGen ExAC gnomAD |
|
CA361103842 rs1482275326 |
251 | M>V | No |
ClinGen gnomAD |
|
rs777476660 CA3430130 |
255 | Y>H | No |
ClinGen ExAC gnomAD |
|
rs200832114 CA128180952 |
258 | P>L | No |
ClinGen TOPMed gnomAD |
|
CA3430132 rs770548315 |
258 | P>S | No |
ClinGen ExAC gnomAD |
|
rs1174428885 CA361104077 |
259 | Q>H | No |
ClinGen TOPMed |
|
CA128180956 rs200009922 |
260 | Q>H | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA3430134 rs759198636 |
263 | D>N | No |
ClinGen ExAC TOPMed gnomAD |
|
rs759198636 CA361104193 |
263 | D>Y | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1580992009 CA361104227 |
265 | G>S | No |
ClinGen Ensembl |
|
CA361104262 rs1416365751 |
267 | G>D | No |
ClinGen gnomAD |
|
rs775094635 CA3430136 |
268 | T>I | No |
ClinGen ExAC gnomAD |
|
CA128180981 rs199646874 |
269 | P>Q | No |
ClinGen Ensembl |
|
CA128180984 rs199646874 |
269 | P>R | No |
ClinGen Ensembl |
|
rs865781599 CA128180989 |
270 | D>G | No |
ClinGen Ensembl |
|
CA3430138 rs762279773 |
270 | D>N | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1485160735 CA361104334 |
271 | Q>L | No |
ClinGen TOPMed |
|
rs1215737762 CA361104365 |
273 | P>T | No |
ClinGen gnomAD |
|
CA128180998 rs974073836 |
275 | Q>* | No |
ClinGen TOPMed |
|
CA128181002 rs866895287 |
276 | G>C | No |
ClinGen Ensembl |
|
TCGA novel | 276 | G>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA3430141 rs568294551 |
279 | S>N | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs200710842 CA3430143 |
279 | S>R | No |
ClinGen ExAC gnomAD |
|
rs1485114313 CA361104501 |
280 | R>C | No |
ClinGen gnomAD |
|
CA361104513 rs1580992102 |
281 | T>P | No |
ClinGen Ensembl |
|
CA3430144 rs755152311 |
281 | T>S | No |
ClinGen ExAC gnomAD |
|
CA128181026 rs868815253 |
283 | Q>P | No |
ClinGen Ensembl |
|
rs200056344 CA128181030 |
284 | P>A | No |
ClinGen gnomAD |
|
rs1167309548 CA361104611 |
285 | S>L | No |
ClinGen gnomAD |
|
rs969339195 CA128181043 |
291 | T>I | No |
ClinGen Ensembl |
|
CA128181050 rs201032646 |
296 | A>V | No |
ClinGen gnomAD |
|
CA128181061 rs201493880 |
297 | T>S | No |
ClinGen Ensembl |
|
rs1580992177 CA361104888 |
302 | Q>R | No |
ClinGen Ensembl |
|
CA3430148 rs777755202 |
303 | D>V | No |
ClinGen ExAC TOPMed gnomAD |
|
CA128181069 rs371702129 |
304 | L>P | No |
ClinGen ESP TOPMed |
|
rs201017327 CA3430149 |
306 | A>T | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs757080248 CA3430150 |
306 | A>V | No |
ClinGen ExAC gnomAD |
|
CA361105099 rs1431546100 |
307 | L>I | No |
ClinGen TOPMed gnomAD |
|
CA3430151 rs781094908 |
308 | N>K | No |
ClinGen ExAC gnomAD |
|
rs1236988714 CA361105199 |
309 | T>I | No |
ClinGen TOPMed gnomAD |
|
CA361105197 rs1236988714 |
309 | T>S | No |
ClinGen TOPMed gnomAD |
|
rs201637316 CA3430152 |
310 | S>G | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA128181084 rs1046797670 |
310 | S>N | No |
ClinGen TOPMed |
|
rs769551859 CA3430153 |
312 | Q>R | No |
ClinGen ExAC gnomAD |
|
CA3430154 rs146282587 |
313 | S>F | No |
ClinGen ESP ExAC TOPMed |
|
CA128181105 rs201831925 |
314 | Q>H | No |
ClinGen Ensembl |
|
TCGA novel | 315 | L>Q | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs1385084693 CA361105395 |
316 | I>V | No |
ClinGen gnomAD |
|
rs1285902502 CA361105455 |
317 | K>N | No |
ClinGen gnomAD |
|
rs1235440886 CA361105480 |
318 | P>S | No |
ClinGen TOPMed |
|
TCGA novel | 320 | R>C | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA361105526 rs1191792029 |
320 | R>L | No |
ClinGen gnomAD |
|
rs772509529 CA3430156 |
322 | R>H | No |
ClinGen ExAC gnomAD |
|
CA3430157 rs773779462 |
323 | K>E | No |
ClinGen ExAC gnomAD |
|
rs1442427059 CA361105662 |
323 | K>R | No |
ClinGen TOPMed |
|
CA361105805 rs1464342926 |
326 | N>K | No |
ClinGen TOPMed gnomAD |
|
rs988622254 CA128181133 |
327 | R>W | No |
ClinGen Ensembl |
|
TCGA novel | 330 | K>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs555144693 CA3430158 |
330 | K>R | No |
ClinGen 1000Genomes ExAC gnomAD |
|
CA361105990 rs1387378079 |
331 | T>A | No |
ClinGen gnomAD |
|
rs1230522969 COSM1433393 CA361105998 |
331 | T>M | large_intestine Variant assessed as Somatic; impact. central_nervous_system [Cosmic, NCI-TCGA] | No |
ClinGen cosmic curated NCI-TCGA gnomAD |
rs1580992292 CA361106012 |
332 | P>S | No |
ClinGen Ensembl |
|
CA3430162 rs776931076 |
333 | P>H | No |
ClinGen ExAC TOPMed gnomAD |
|
rs776931076 CA128181145 |
333 | P>L | No |
ClinGen ExAC TOPMed gnomAD |
|
CA3430161 rs776931076 |
333 | P>R | No |
ClinGen ExAC TOPMed gnomAD |
|
rs201213506 CA3430164 |
334 | H>D | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
CA3430163 rs201213506 |
334 | H>N | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
rs746692720 | 334 | H>P | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No | NCI-TCGA |
rs1304806674 CA361106107 |
334 | H>Q | No |
ClinGen gnomAD |
|
rs746692720 | 334 | H>T | Variant assessed as Somatic; 4.65e-05 impact. [NCI-TCGA] | No | NCI-TCGA |
CA3430165 rs201213506 |
334 | H>Y | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
rs764015540 CA3430166 |
338 | Y>F | No |
ClinGen ExAC TOPMed gnomAD |
|
CA361106257 rs202118818 |
339 | A>G | No |
ClinGen TOPMed gnomAD |
|
rs202118818 CA128181161 |
339 | A>V | No |
ClinGen TOPMed gnomAD |
|
rs745631772 CA3430171 |
344 | S>A | No |
ClinGen ExAC gnomAD |
|
CA361106448 rs1431269827 |
346 | D>N | No |
ClinGen TOPMed gnomAD |
|
CA361106483 rs1183670804 |
347 | R>H | No |
ClinGen gnomAD |
|
rs201517117 CA128181194 |
348 | R>C | No |
ClinGen ExAC gnomAD |
|
rs201517117 CA3430173 |
348 | R>G | No |
ClinGen ExAC gnomAD |
|
CA3430174 rs748831364 |
348 | R>H | No |
ClinGen ExAC TOPMed |
|
CA128181201 rs577439715 |
350 | S>P | No |
ClinGen 1000Genomes |
|
CA361106551 rs1158530364 |
351 | R>C | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
TCGA novel | 351 | R>H | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs1411364349 CA361106577 |
352 | S>C | No |
ClinGen TOPMed |
|
rs773690840 CA3430176 |
356 | T>P | No |
ClinGen ExAC gnomAD |
|
rs931624345 CA128181214 |
359 | I>T | No |
ClinGen gnomAD |
|
CA361106794 rs1286054246 |
362 | H>Y | No |
ClinGen gnomAD |
|
TCGA novel | 364 | G>Q | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
COSM1186840 CA3430182 rs775787059 |
371 | R>H | lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] | No |
ClinGen cosmic curated ExAC NCI-TCGA gnomAD |
CA361107242 rs1487438114 |
379 | R>C | No |
ClinGen gnomAD |
|
TCGA novel | 385 | T>I | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA3430185 rs751573105 |
390 | H>D | No |
ClinGen ExAC gnomAD |
|
rs1437446571 CA361107838 |
401 | C>Y | No |
ClinGen TOPMed |
|
CA361108079 rs1561814597 |
411 | R>H | No |
ClinGen Ensembl |
|
rs1440102254 CA361108124 |
413 | R>K | No |
ClinGen TOPMed |
|
CA361108165 rs1561814606 |
414 | H>L | No |
ClinGen Ensembl |
|
CA361108158 rs1397728528 |
414 | H>Y | No |
ClinGen gnomAD |
|
rs535038686 CA361108307 |
419 | L>M | No |
ClinGen 1000Genomes ExAC gnomAD |
|
CA361108362 rs1166693992 |
420 | R>P | No |
ClinGen TOPMed |
|
TCGA novel | 420 | R>W | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA3430189 rs755983566 |
423 | D>N | No |
ClinGen ExAC TOPMed gnomAD |
|
rs779644730 CA3430190 |
424 | K>R | No |
ClinGen ExAC gnomAD |
|
CA361108583 rs1229612199 |
426 | A>T | No |
ClinGen gnomAD |
|
CA361108651 rs1166167763 |
428 | K>E | No |
ClinGen TOPMed |
|
CA3430193 rs373411522 |
431 | V>A | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA361108822 rs1390264560 |
434 | S>P | No |
ClinGen TOPMed |
|
TCGA novel | 435 | A>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA361108873 rs1580992480 |
436 | T>P | No |
ClinGen Ensembl |
|
rs201394271 CA3430197 |
437 | S>P | No |
ClinGen ExAC TOPMed gnomAD |
|
rs534778183 CA128181276 |
441 | S>C | No |
ClinGen Ensembl |
|
CA3430200 rs746308508 |
442 | Y>S | No |
ClinGen ExAC gnomAD |
|
CA361109072 rs1422118092 |
443 | P>R | No |
ClinGen gnomAD |
|
CA361109116 rs1173220892 |
445 | P>L | No |
ClinGen gnomAD |
|
rs201552434 CA128181289 |
447 | A>T | No |
ClinGen TOPMed |
|
CA361109241 rs1167047514 |
449 | S>C | No |
ClinGen gnomAD |
|
CA361109291 rs1376911505 |
451 | P>L | No |
ClinGen gnomAD |
|
rs1376911505 CA361109289 |
451 | P>Q | No |
ClinGen gnomAD |
|
rs1365462911 CA361109319 |
453 | P>S | No |
ClinGen TOPMed |
|
CA128181302 rs865951226 |
454 | V>A | No |
ClinGen gnomAD |
|
CA3430205 rs763286707 |
454 | V>L | No |
ClinGen ExAC gnomAD |
|
rs149798677 CA128181304 |
455 | T>A | No |
ClinGen 1000Genomes ESP TOPMed gnomAD |
|
rs768733193 CA3430207 |
456 | T>I | No |
ClinGen ExAC gnomAD |
|
CA361109411 rs1364304172 |
457 | S>F | No |
ClinGen gnomAD |
|
rs1282108476 CA361109483 |
459 | P>L | No |
ClinGen gnomAD |
|
CA3430210 rs774561952 |
459 | P>S | No |
ClinGen ExAC gnomAD |
|
rs1348315466 CA361109542 |
461 | P>L | No |
ClinGen TOPMed gnomAD |
|
rs1370589212 CA361109554 |
462 | A>T | No |
ClinGen TOPMed |
|
CA3430212 rs767650411 |
463 | T>A | No |
ClinGen ExAC gnomAD |
|
rs200048883 CA128181327 |
464 | T>S | No |
ClinGen Ensembl |
|
CA3430214 rs760644725 |
465 | S>L | No |
ClinGen ExAC gnomAD |
|
CA3430215 rs370248873 |
469 | P>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs1192140857 CA361109783 |
471 | P>H | No |
ClinGen TOPMed |
|
rs753553653 CA3430216 |
472 | T>A | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1435715856 CA361109852 |
474 | F>L | No |
ClinGen gnomAD |
|
CA3430219 rs202226814 |
477 | P>A | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs1387817209 COSM735540 CA361109984 |
480 | S>L | lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] | No |
ClinGen cosmic curated NCI-TCGA gnomAD |
rs922456828 CA128181347 |
481 | T>I | No |
ClinGen TOPMed |
|
CA361110014 rs1580992644 |
482 | Y>S | No |
ClinGen Ensembl |
|
CA128181350 rs955227243 |
485 | P>R | No |
ClinGen TOPMed |
|
CA361110107 rs1580992653 |
487 | H>P | No |
ClinGen Ensembl |
|
TCGA novel | 489 | G>D | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs1286256447 CA361110185 |
490 | F>C | No |
ClinGen TOPMed |
|
CA3430227 rs768984243 |
492 | S>F | No |
ClinGen ExAC gnomAD |
|
rs199867643 CA3430226 |
492 | S>P | No |
ClinGen ExAC gnomAD |
|
CA361110248 COSM1061394 rs1296620472 |
493 | P>L | Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated NCI-TCGA gnomAD |
CA361110278 rs1561814777 |
495 | V>A | No |
ClinGen Ensembl |
|
CA3430228 rs774453334 |
496 | A>P | No |
ClinGen ExAC gnomAD |
|
CA3430229 rs140128606 |
497 | T>I | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA361110332 rs1207458162 |
498 | T>M | No |
ClinGen gnomAD |
|
rs1372874718 CA361110355 |
499 | Y>* | No |
ClinGen TOPMed gnomAD |
|
rs1396385681 CA361110379 |
501 | S>P | No |
ClinGen gnomAD |
|
CA3430231 rs773373715 |
503 | P>S | No |
ClinGen ExAC gnomAD |
|
rs766194467 CA361110452 |
505 | A>S | No |
ClinGen ExAC gnomAD |
|
CA3430233 rs766194467 |
505 | A>T | No |
ClinGen ExAC gnomAD |
|
CA128181378 rs200268457 |
507 | P>L | No |
ClinGen TOPMed gnomAD |
|
CA128181375 rs376532290 |
507 | P>S | No |
ClinGen ESP TOPMed |
|
rs915368252 CA128181407 |
510 | V>A | No |
ClinGen Ensembl |
|
TCGA novel | 512 | S>C | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs145540497 CA3430236 |
512 | S>I | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs1327890220 CA361110624 |
513 | F>L | No |
ClinGen gnomAD |
|
rs757997080 CA3430238 |
517 | A>T | No |
ClinGen ExAC gnomAD |
|
rs751040100 CA3430240 |
519 | T>S | No |
ClinGen ExAC gnomAD |
|
rs758418994 CA128181424 |
522 | F>I | No |
ClinGen gnomAD |
|
rs1319830395 CA361110750 |
523 | S>G | No |
ClinGen TOPMed gnomAD |
|
CA361110749 rs1319830395 |
523 | S>R | No |
ClinGen TOPMed gnomAD |
|
rs1226620293 CA361110781 |
524 | A>D | No |
ClinGen gnomAD |
|
rs147752848 CA361110773 |
524 | A>S | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
rs147752848 CA3430242 |
524 | A>T | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
CA3430243 rs749750277 |
526 | T>S | No |
ClinGen ExAC TOPMed gnomAD |
|
rs371059427 CA3430244 |
529 | S>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA128181436 rs748400232 |
530 | D>G | No |
ClinGen ExAC TOPMed gnomAD |
|
CA3430246 rs748400232 |
530 | D>V | No |
ClinGen ExAC TOPMed gnomAD |
|
CA3430247 rs772398081 |
531 | M>T | No |
ClinGen ExAC gnomAD |
|
rs773465307 CA3430248 |
532 | T>A | No |
ClinGen ExAC gnomAD |
|
rs202136756 CA128181442 |
534 | T>N | No |
ClinGen TOPMed |
|
rs1166405541 CA361111048 |
536 | S>P | No |
ClinGen gnomAD |
|
rs1404629415 CA361111153 |
540 | I>T | No |
ClinGen gnomAD |
|
rs776445332 CA3430251 |
540 | I>V | No |
ClinGen ExAC gnomAD |
|
rs759479225 CA3430252 |
542 | I>V | No |
ClinGen ExAC TOPMed gnomAD |
|
CA3430253 rs764964083 |
543 | C>Y | No |
ClinGen ExAC TOPMed gnomAD |
No associated diseases with P18146
5 regional properties for P18146
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Protein kinase domain | 12 - 264 | IPR000719 |
domain | NAF domain | 294 - 351 | IPR004041 |
active_site | Serine/threonine-protein kinase, active site | 130 - 142 | IPR008271 |
binding_site | Protein kinase, ATP binding site | 18 - 41 | IPR017441 |
domain | NAF/FISL domain | 291 - 315 | IPR018451 |
4 GO annotations of cellular component
Name | Definition |
---|---|
chromatin | The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. |
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
14 GO annotations of molecular function
Name | Definition |
---|---|
DNA binding | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
DNA-binding transcription activator activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that activates or increases transcription of specific gene sets transcribed by RNA polymerase II. |
DNA-binding transcription factor activity | A transcription regulator activity that modulates transcription of gene sets via selective and non-covalent binding to a specific double-stranded genomic DNA sequence (sometimes referred to as a motif) within a cis-regulatory region. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons. |
DNA-binding transcription factor activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II. |
double-stranded methylated DNA binding | Binding to double-stranded methylated DNA. Methylation of cytosine or adenine in DNA is an important mechanism for establishing stable heritable epigenetic marks. |
hemi-methylated DNA-binding | Binding to double-stranded hemi-methylated DNA at replication foci (one strand methylated, while the other strand is unmethylated). Methylation of cytosine or adenine in DNA is an important mechanism for establishing stable heritable epigenetic marks. |
histone acetyltransferase binding | Binding to an histone acetyltransferase. |
promoter-specific chromatin binding | Binding to a section of chromatin that is associated with gene promoter sequences of DNA. |
RNA polymerase II cis-regulatory region sequence-specific DNA binding | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. |
RNA polymerase II transcription regulatory region sequence-specific DNA binding | Binding to a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II. |
sequence-specific DNA binding | Binding to DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding. |
sequence-specific double-stranded DNA binding | Binding to double-stranded DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA, e.g. promotor binding or rDNA binding. |
transcription cis-regulatory region binding | Binding to a specific sequence of DNA that is part of a regulatory region that controls transcription of that section of the DNA. The transcribed region might be described as a gene, cistron, or operon. |
zinc ion binding | Binding to a zinc ion (Zn). |
35 GO annotations of biological process
Name | Definition |
---|---|
BMP signaling pathway | The series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
cellular response to gamma radiation | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum. |
cellular response to heparin | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heparin stimulus. |
cellular response to interleukin-8 | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-8 stimulus. |
cellular response to mycophenolic acid | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mycophenolic acid stimulus. |
circadian regulation of gene expression | Any process that modulates the frequency, rate or extent of gene expression such that an expression pattern recurs with a regularity of approximately 24 hours. |
circadian temperature homeostasis | Any homeostatic process in which an organism modulates its internal body temperature at different values with a regularity of approximately 24 hours. |
estrous cycle | A type of ovulation cycle, which occurs in most mammalian therian females, where the endometrium is resorbed if pregnancy does not occur. |
glomerular mesangial cell proliferation | The multiplication or reproduction of glomerular mesangial cells, resulting in the expansion of the population. |
interleukin-1-mediated signaling pathway | The series of molecular signals initiated by interleukin-1 binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
locomotor rhythm | The rhythm of the locomotor activity of an organism during its 24 hour activity cycle. |
negative regulation of canonical Wnt signaling pathway | Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. |
negative regulation of transcription by RNA polymerase II | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. |
positive regulation of chemokine production | Any process that activates or increases the frequency, rate, or extent of chemokine production. |
positive regulation of DNA-templated transcription | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
positive regulation of gene expression | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
positive regulation of glomerular metanephric mesangial cell proliferation | Any process that increases the frequency, rate or extent of metanephric glomerular mesangial cell proliferation. |
positive regulation of hormone biosynthetic process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of hormones. |
positive regulation of interleukin-1 beta production | Any process that activates or increases the frequency, rate, or extent of interleukin-1 beta production. |
positive regulation of miRNA transcription | Any process that activates or increases the frequency, rate or extent of microRNA (miRNA) gene transcription. |
positive regulation of neuron death | Any process that activates or increases the frequency, rate or extent of neuron death. |
positive regulation of post-translational protein modification | Any process that activates or increases the frequency, rate or extent of post-translational protein modification. |
positive regulation of tau-protein kinase activity | Any process that activates or increases the frequency, rate or extent of tau-protein kinase activity. |
positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
regulation of apoptotic process | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
regulation of progesterone biosynthetic process | Any process that modulates the frequency, rate or extent of progesterone biosynthetic process. |
regulation of protein sumoylation | Any process that modulates the frequency, rate or extent of the addition of SUMO groups to a protein. |
regulation of transcription by RNA polymerase II | Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. |
regulation of transcription from RNA polymerase II promoter in response to hypoxia | Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus. |
response to glucose | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus. |
response to hypoxia | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
response to insulin | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. |
response to ischemia | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a inadequate blood supply. |
skeletal muscle cell differentiation | The process in which a relatively unspecialized cell acquires specialized features of a skeletal muscle cell, a somatic cell located in skeletal muscle. |
T cell differentiation | The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex. |
177 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q08DS3 | OSR1 | Protein odd-skipped-related 1 | Bos taurus (Bovine) | PR |
Q2VWH6 | FEZF2 | Fez family zinc finger protein 2 | Bos taurus (Bovine) | PR |
A6QNZ0 | ZSCAN26 | Zinc finger and SCAN domain-containing protein 26 | Bos taurus (Bovine) | PR |
A7MBI1 | ZFP69 | Zinc finger protein 69 homolog | Bos taurus (Bovine) | PR |
Q08705 | CTCF | Transcriptional repressor CTCF | Gallus gallus (Chicken) | PR |
O42409 | GFI1B | Zinc finger protein Gfi-1b | Gallus gallus (Chicken) | PR |
A2T6W2 | ZNF449 | Zinc finger protein 449 | Pan troglodytes (Chimpanzee) | PR |
Q9U405 | grau | Transcription factor grauzone | Drosophila melanogaster (Fruit fly) | PR |
Q7K0S9 | sug | Zinc finger protein GLIS2 homolog | Drosophila melanogaster (Fruit fly) | PR |
P20385 | Cf2 | Chorion transcription factor Cf2 | Drosophila melanogaster (Fruit fly) | PR |
Q86P48 | ATbp | AT-rich binding protein | Drosophila melanogaster (Fruit fly) | PR |
P28698 | MZF1 | Myeloid zinc finger 1 | Homo sapiens (Human) | PR |
Q9NTW7 | ZFP64 | Zinc finger protein 64 | Homo sapiens (Human) | PR |
O14978 | ZNF263 | Zinc finger protein 263 | Homo sapiens (Human) | PR |
O60304 | ZNF500 | Zinc finger protein 500 | Homo sapiens (Human) | PR |
P08151 | GLI1 | Zinc finger protein GLI1 | Homo sapiens (Human) | PR |
Q9UFB7 | ZBTB47 | Zinc finger and BTB domain-containing protein 47 | Homo sapiens (Human) | PR |
Q9UNY5 | ZNF232 | Zinc finger protein 232 | Homo sapiens (Human) | PR |
Q96SZ4 | ZSCAN10 | Zinc finger and SCAN domain-containing protein 10 | Homo sapiens (Human) | PR |
P17028 | ZNF24 | Zinc finger protein 24 | Homo sapiens (Human) | PR |
P25490 | YY1 | Transcriptional repressor protein YY1 | Homo sapiens (Human) | SS |
O43296 | ZNF264 | Zinc finger protein 264 | Homo sapiens (Human) | PR |
P49711 | CTCF | Transcriptional repressor CTCF | Homo sapiens (Human) | PR |
Q9NQX1 | PRDM5 | PR domain zinc finger protein 5 | Homo sapiens (Human) | PR |
Q9HBE1 | PATZ1 | POZ-, AT hook-, and zinc finger-containing protein 1 | Homo sapiens (Human) | PR |
Q8TAX0 | OSR1 | Protein odd-skipped-related 1 | Homo sapiens (Human) | PR |
Q9UL58 | ZNF215 | Zinc finger protein 215 | Homo sapiens (Human) | PR |
Q8TBJ5 | FEZF2 | Fez family zinc finger protein 2 | Homo sapiens (Human) | PR |
Q96SR6 | ZNF382 | Zinc finger protein 382 | Homo sapiens (Human) | PR |
Q96IT1 | ZNF496 | Zinc finger protein 496 | Homo sapiens (Human) | PR |
Q96N95 | ZNF396 | Zinc finger protein 396 | Homo sapiens (Human) | PR |
Q9ULJ3 | ZBTB21 | Zinc finger and BTB domain-containing protein 21 | Homo sapiens (Human) | PR |
Q9H9D4 | ZNF408 | Zinc finger protein 408 | Homo sapiens (Human) | PR |
Q13127 | REST | RE1-silencing transcription factor | Homo sapiens (Human) | PR |
Q8IZM8 | ZNF654 | Zinc finger protein 654 | Homo sapiens (Human) | PR |
Q14526 | HIC1 | Hypermethylated in cancer 1 protein | Homo sapiens (Human) | PR |
P17022 | ZNF18 | Zinc finger protein 18 | Homo sapiens (Human) | PR |
Q86XF7 | ZNF575 | Zinc finger protein 575 | Homo sapiens (Human) | PR |
Q8NAM6 | ZSCAN4 | Zinc finger and SCAN domain-containing protein 4 | Homo sapiens (Human) | PR |
Q08ER8 | ZNF543 | Zinc finger protein 543 | Homo sapiens (Human) | PR |
P17029 | ZKSCAN1 | Zinc finger protein with KRAB and SCAN domains 1 | Homo sapiens (Human) | PR |
Q8N680 | ZBTB2 | Zinc finger and BTB domain-containing protein 2 | Homo sapiens (Human) | PR |
O95625 | ZBTB11 | Zinc finger and BTB domain-containing protein 11 | Homo sapiens (Human) | PR |
Q9NPC7 | MYNN | Myoneurin | Homo sapiens (Human) | PR |
Q96BV0 | ZNF775 | Zinc finger protein 775 | Homo sapiens (Human) | PR |
Q8NF99 | ZNF397 | Zinc finger protein 397 | Homo sapiens (Human) | PR |
Q63HK3 | ZKSCAN2 | Zinc finger protein with KRAB and SCAN domains 2 | Homo sapiens (Human) | PR |
Q5FWF6 | ZNF789 | Zinc finger protein 789 | Homo sapiens (Human) | PR |
Q15776 | ZKSCAN8 | Zinc finger protein with KRAB and SCAN domains 8 | Homo sapiens (Human) | PR |
Q53GI3 | ZNF394 | Zinc finger protein 394 | Homo sapiens (Human) | PR |
O95125 | ZNF202 | Zinc finger protein 202 | Homo sapiens (Human) | PR |
Q05516 | ZBTB16 | Zinc finger and BTB domain-containing protein 16 | Homo sapiens (Human) | PR |
Q9H116 | GZF1 | GDNF-inducible zinc finger protein 1 | Homo sapiens (Human) | PR |
Q8N0Y2 | ZNF444 | Zinc finger protein 444 | Homo sapiens (Human) | PR |
Q6P9G9 | ZNF449 | Zinc finger protein 449 | Homo sapiens (Human) | PR |
Q8IW36 | ZNF695 | Zinc finger protein 695 | Homo sapiens (Human) | PR |
Q5VTD9 | GFI1B | Zinc finger protein Gfi-1b | Homo sapiens (Human) | PR |
Q6PG37 | ZNF790 | Zinc finger protein 790 | Homo sapiens (Human) | PR |
Q9NQV6 | PRDM10 | PR domain zinc finger protein 10 | Homo sapiens (Human) | PR |
Q9Y2D9 | ZNF652 | Zinc finger protein 652 | Homo sapiens (Human) | PR |
Q5TC79 | ZBTB37 | Zinc finger and BTB domain-containing protein 37 | Homo sapiens (Human) | PR |
Q9Y4E5 | ZNF451 | E3 SUMO-protein ligase ZNF451 | Homo sapiens (Human) | PR |
Q8ND82 | ZNF280C | Zinc finger protein 280C | Homo sapiens (Human) | PR |
Q49AA0 | ZFP69 | Zinc finger protein 69 homolog | Homo sapiens (Human) | PR |
O43298 | ZBTB43 | Zinc finger and BTB domain-containing protein 43 | Homo sapiens (Human) | PR |
Q9Y330 | ZBTB12 | Zinc finger and BTB domain-containing protein 12 | Homo sapiens (Human) | PR |
Q13105 | ZBTB17 | Zinc finger and BTB domain-containing protein 17 | Homo sapiens (Human) | PR |
P51508 | ZNF81 | Zinc finger protein 81 | Homo sapiens (Human) | PR |
Q5JNZ3 | ZNF311 | Zinc finger protein 311 | Homo sapiens (Human) | PR |
Q9BRR0 | ZKSCAN3 | Zinc finger protein with KRAB and SCAN domains 3 | Homo sapiens (Human) | PR |
Q969J2 | ZKSCAN4 | Zinc finger protein with KRAB and SCAN domains 4 | Homo sapiens (Human) | PR |
P49910 | ZNF165 | Zinc finger protein 165 | Homo sapiens (Human) | PR |
P10074 | ZBTB48 | Telomere zinc finger-associated protein | Homo sapiens (Human) | PR |
P17010 | ZFX | Zinc finger X-chromosomal protein | Homo sapiens (Human) | PR |
Q9H5H4 | ZNF768 | Zinc finger protein 768 | Homo sapiens (Human) | PR |
Q6NSZ9 | ZSCAN25 | Zinc finger and SCAN domain-containing protein 25 | Homo sapiens (Human) | PR |
Q9Y2L8 | ZKSCAN5 | Zinc finger protein with KRAB and SCAN domains 5 | Homo sapiens (Human) | PR |
Q86UZ6 | ZBTB46 | Zinc finger and BTB domain-containing protein 46 | Homo sapiens (Human) | PR |
Q9NX65 | ZSCAN32 | Zinc finger and SCAN domain-containing protein 32 | Homo sapiens (Human) | PR |
O14771 | ZNF213 | Zinc finger protein 213 | Homo sapiens (Human) | PR |
Q8IWY8 | ZSCAN29 | Zinc finger and SCAN domain-containing protein 29 | Homo sapiens (Human) | PR |
Q8NCP5 | ZBTB44 | Zinc finger and BTB domain-containing protein 44 | Homo sapiens (Human) | PR |
P41182 | BCL6 | B-cell lymphoma 6 protein | Homo sapiens (Human) | PR |
Q9NQX0 | PRDM6 | Putative histone-lysine N-methyltransferase PRDM6 | Homo sapiens (Human) | PR |
Q9BU19 | ZNF692 | Zinc finger protein 692 | Homo sapiens (Human) | PR |
Q08AG5 | ZNF844 | Zinc finger protein 844 | Homo sapiens (Human) | PR |
Q6R2W3 | ZBED9 | SCAN domain-containing protein 3 | Homo sapiens (Human) | PR |
P98182 | ZNF200 | Zinc finger protein 200 | Homo sapiens (Human) | PR |
Q9UK11 | ZNF223 | Zinc finger protein 223 | Homo sapiens (Human) | PR |
O15156 | ZBTB7B | Zinc finger and BTB domain-containing protein 7B | Homo sapiens (Human) | PR |
Q6ZMS7 | ZNF783 | Zinc finger protein 783 | Homo sapiens (Human) | PR |
P59923 | ZNF445 | Zinc finger protein 445 | Homo sapiens (Human) | PR |
Q8N859 | ZNF713 | Zinc finger protein 713 | Homo sapiens (Human) | PR |
Q8TD17 | ZNF398 | Zinc finger protein 398 | Homo sapiens (Human) | PR |
P52739 | ZNF131 | Zinc finger protein 131 | Homo sapiens (Human) | PR |
A6NGD5 | ZSCAN5C | Zinc finger and SCAN domain-containing protein 5C | Homo sapiens (Human) | PR |
Q7Z398 | ZNF550 | Zinc finger protein 550 | Homo sapiens (Human) | PR |
Q9Y2K1 | ZBTB1 | Zinc finger and BTB domain-containing protein 1 | Homo sapiens (Human) | PR |
Q96N20 | ZNF75A | Zinc finger protein 75A | Homo sapiens (Human) | PR |
A6NJL1 | ZSCAN5B | Zinc finger and SCAN domain-containing protein 5B | Homo sapiens (Human) | PR |
A1YPR0 | ZBTB7C | Zinc finger and BTB domain-containing protein 7C | Homo sapiens (Human) | PR |
Q9NWS9 | ZNF446 | Zinc finger protein 446 | Homo sapiens (Human) | PR |
P24278 | ZBTB25 | Zinc finger and BTB domain-containing protein 25 | Homo sapiens (Human) | PR |
Q96N38 | ZNF714 | Zinc finger protein 714 | Homo sapiens (Human) | PR |
Q86YH2 | ZNF280B | Zinc finger protein 280B | Homo sapiens (Human) | PR |
Q05215 | EGR4 | Early growth response protein 4 | Homo sapiens (Human) | PR |
Q9Y5W3 | KLF2 | Krueppel-like factor 2 | Homo sapiens (Human) | PR |
Q06889 | EGR3 | Early growth response protein 3 | Homo sapiens (Human) | PR |
Q9Y4X4 | KLF12 | Krueppel-like factor 12 | Homo sapiens (Human) | PR |
Q99612 | KLF6 | Krueppel-like factor 6 | Homo sapiens (Human) | PR |
O75840 | KLF7 | Krueppel-like factor 7 | Homo sapiens (Human) | PR |
P57682 | KLF3 | Krueppel-like factor 3 | Homo sapiens (Human) | PR |
O08584 | Klf6 | Krueppel-like factor 6 | Mus musculus (Mouse) | PR |
Q61164 | Ctcf | Transcriptional repressor CTCF | Mus musculus (Mouse) | PR |
Q810A1 | Znf18 | Zinc finger protein 18 | Mus musculus (Mouse) | PR |
Q8BGS3 | Zkscan1 | Zinc finger protein with KRAB and SCAN domains 1 | Mus musculus (Mouse) | PR |
Q00899 | Yy1 | Transcriptional repressor protein YY1 | Mus musculus (Mouse) | PR |
P41183 | Bcl6 | B-cell lymphoma 6 protein homolog | Mus musculus (Mouse) | PR |
Q9DAI4 | Zbtb43 | Zinc finger and BTB domain-containing protein 43 | Mus musculus (Mouse) | PR |
O70237 | Gfi1b | Zinc finger protein Gfi-1b | Mus musculus (Mouse) | PR |
Q99KZ6 | Znf639 | Zinc finger protein 639 | Mus musculus (Mouse) | PR |
Q9Z1D9 | Znf394 | Zinc finger protein 394 | Mus musculus (Mouse) | PR |
Q9CXE0 | Prdm5 | PR domain zinc finger protein 5 | Mus musculus (Mouse) | PR |
P43300 | Egr3 | Early growth response protein 3 | Mus musculus (Mouse) | PR |
Q9DAU9 | Znf654 | Zinc finger protein 654 | Mus musculus (Mouse) | PR |
Q9R1Y5 | Hic1 | Hypermethylated in cancer 1 protein | Mus musculus (Mouse) | PR |
Q8R0T2 | Znf768 | Zinc finger protein 768 | Mus musculus (Mouse) | PR |
Q9WVG7 | Osr1 | Protein odd-skipped-related 1 | Mus musculus (Mouse) | PR |
Q8BI73 | Znf775 | Zinc finger protein 775 | Mus musculus (Mouse) | PR |
Q8VCZ7 | Zbtb7c | Zinc finger and BTB domain-containing protein 7C | Mus musculus (Mouse) | PR |
Q91VN1 | Znf24 | Zinc finger protein 24 | Mus musculus (Mouse) | PR |
Q9DB38 | Znf580 | Zinc finger protein 580 | Mus musculus (Mouse) | PR |
A7KBS4 | Zscan4d | Zinc finger and SCAN domain containing protein 4D | Mus musculus (Mouse) | PR |
Q91VW9 | Zkscan3 | Zinc finger protein with KRAB and SCAN domains 3 | Mus musculus (Mouse) | PR |
P10925 | Zfy1 | Zinc finger Y-chromosomal protein 1 | Mus musculus (Mouse) | PR |
Q3TTC2 | Yy2 | Transcription factor YY2 | Mus musculus (Mouse) | PR |
Q3UTQ7 | Prdm10 | PR domain zinc finger protein 10 | Mus musculus (Mouse) | PR |
Q6P3Y5 | Znf280c | Zinc finger protein 280C | Mus musculus (Mouse) | PR |
Q9ERU3 | Znf22 | Zinc finger protein 22 | Mus musculus (Mouse) | PR |
Q8VIG1 | Rest | RE1-silencing transcription factor | Mus musculus (Mouse) | PR |
Q9Z1D8 | Zkscan5 | Zinc finger protein with KRAB and SCAN domains 5 | Mus musculus (Mouse) | PR |
Q8BID6 | Zbtb46 | Zinc finger and BTB domain-containing protein 46 | Mus musculus (Mouse) | PR |
P17012 | Zfx | Zinc finger X-chromosomal protein | Mus musculus (Mouse) | PR |
Q9WUK6 | Zbtb18 | Zinc finger and BTB domain-containing protein 18 | Mus musculus (Mouse) | PR |
O35738 | Klf12 | Krueppel-like factor 12 | Mus musculus (Mouse) | PR |
B2RXC5 | Znf382 | Zinc finger protein 382 | Mus musculus (Mouse) | PR |
O08900 | Ikzf3 | Zinc finger protein Aiolos | Mus musculus (Mouse) | PR |
Q5DU09 | Znf652 | Zinc finger protein 652 | Mus musculus (Mouse) | PR |
Q5RJ54 | Zscan26 | Zinc finger and SCAN domain-containing protein 26 | Mus musculus (Mouse) | PR |
Q8BLM0 | Klf8 | Krueppel-like factor 8 | Mus musculus (Mouse) | PR |
Q99JB0 | Klf7 | Krueppel-like factor 7 | Mus musculus (Mouse) | PR |
Q8R0A2 | Zbtb44 | Zinc finger and BTB domain-containing protein 44 | Mus musculus (Mouse) | PR |
P20662 | Zfy2 | Zinc finger Y-chromosomal protein 2 | Mus musculus (Mouse) | PR |
Q80VJ6 | Zscan4c | Zinc finger and SCAN domain containing protein 4C | Mus musculus (Mouse) | PR |
Q3URS2 | Zscan4f | Zinc finger and SCAN domain containing protein 4F | Mus musculus (Mouse) | PR |
Q60980 | Klf3 | Krueppel-like factor 3 | Mus musculus (Mouse) | PR |
Q8K3J5 | Znf131 | Zinc finger protein 131 | Mus musculus (Mouse) | PR |
P08046 | Egr1 | Early growth response protein 1 | Mus musculus (Mouse) | PR |
Q9Z2K3 | Znf394 | Zinc finger protein 394 | Rattus norvegicus (Rat) | PR |
Q642B9 | Znf18 | Zinc finger protein 18 | Rattus norvegicus (Rat) | PR |
B0K011 | Osr1 | Protein odd-skipped-related 1 | Rattus norvegicus (Rat) | PR |
D3ZUU2 | Gzf1 | GDNF-inducible zinc finger protein 1 | Rattus norvegicus (Rat) | PR |
B1WBU4 | Zbtb8a | Zinc finger and BTB domain-containing protein 8A | Rattus norvegicus (Rat) | PR |
Q7TNK3 | Znf24 | Zinc finger protein 24 | Rattus norvegicus (Rat) | PR |
O35819 | Klf6 | Krueppel-like factor 6 | Rattus norvegicus (Rat) | PR |
Q9R1D1 | Ctcf | Transcriptional repressor CTCF | Rattus norvegicus (Rat) | PR |
A0JPL0 | Znf382 | Zinc finger protein 382 | Rattus norvegicus (Rat) | PR |
Q4KLI1 | Zkscan1 | Zinc finger protein with KRAB and SCAN domains 1 | Rattus norvegicus (Rat) | PR |
A1L1J6 | Znf652 | Zinc finger protein 652 | Rattus norvegicus (Rat) | PR |
P43301 | Egr3 | Early growth response protein 3 | Rattus norvegicus (Rat) | PR |
P08154 | Egr1 | Early growth response protein 1 | Rattus norvegicus (Rat) | PR |
Q9SHD0 | ZAT4 | Zinc finger protein ZAT4 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q0P4X6 | zbtb44 | Zinc finger and BTB domain-containing protein 44 | Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) | PR |
Q6P882 | zbtb8a.2 | Zinc finger and BTB domain-containing protein 8A.2 | Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) | PR |
A4II20 | egr1 | Early growth response protein 1 | Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) | PR |
Q567C6 | znf367 | Zinc finger protein 367 | Danio rerio (Zebrafish) (Brachydanio rerio) | PR |
A7Y7X5 | znf711 | Zinc finger protein 711 | Danio rerio (Zebrafish) (Brachydanio rerio) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MAAAKAEMQL | MSPLQISDPF | GSFPHSPTMD | NYPKLEEMML | LSNGAPQFLG | AAGAPEGSGS |
70 | 80 | 90 | 100 | 110 | 120 |
NSSSSSSGGG | GGGGGGSNSS | SSSSTFNPQA | DTGEQPYEHL | TAESFPDISL | NNEKVLVETS |
130 | 140 | 150 | 160 | 170 | 180 |
YPSQTTRLPP | ITYTGRFSLE | PAPNSGNTLW | PEPLFSLVSG | LVSMTNPPAS | SSSAPSPAAS |
190 | 200 | 210 | 220 | 230 | 240 |
SASASQSPPL | SCAVPSNDSS | PIYSAAPTFP | TPNTDIFPEP | QSQAFPGSAG | TALQYPPPAY |
250 | 260 | 270 | 280 | 290 | 300 |
PAAKGGFQVP | MIPDYLFPQQ | QGDLGLGTPD | QKPFQGLESR | TQQPSLTPLS | TIKAFATQSG |
310 | 320 | 330 | 340 | 350 | 360 |
SQDLKALNTS | YQSQLIKPSR | MRKYPNRPSK | TPPHERPYAC | PVESCDRRFS | RSDELTRHIR |
370 | 380 | 390 | 400 | 410 | 420 |
IHTGQKPFQC | RICMRNFSRS | DHLTTHIRTH | TGEKPFACDI | CGRKFARSDE | RKRHTKIHLR |
430 | 440 | 450 | 460 | 470 | 480 |
QKDKKADKSV | VASSATSSLS | SYPSPVATSY | PSPVTTSYPS | PATTSYPSPV | PTSFSSPGSS |
490 | 500 | 510 | 520 | 530 | 540 |
TYPSPVHSGF | PSPSVATTYS | SVPPAFPAQV | SSFPSSAVTN | SFSASTGLSD | MTATFSPRTI |
EIC |